Company news
Amphastar Pharmaceuticals, Inc. news in 2020
Amphastar Pharmaceuticals, Inc.'s news releases, calls and decks from 2020, newest first.
Amphastar Announces Approval for Glucagon for Injection Kit, 1mg
December 28, 2020
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2020
November 5, 2020
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2020
October 28, 2020
Amphastar Pharmaceuticals Receives FDA Approval for Atropine Sulfate Injection
October 5, 2020
Amphastar Pharmaceuticals to Present at the Wells Fargo 2020 Virtual Healthcare Conference
September 2, 2020
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2020
August 5, 2020
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020
July 29, 2020
Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
June 18, 2020
Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference
June 11, 2020
Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial
June 8, 2020
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2020
May 6, 2020
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2020
May 3, 2020
Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial
April 26, 2020
Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure
April 12, 2020
Amphastar Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference
April 8, 2020
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2019
March 11, 2020
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12th, 2020
March 4, 2020
Amphastar Pharmaceuticals Receives FDA Approval for Supplement to its Abbreviated New Drug Application for Sodium Bicarbonate Injection, USP 8.4%, 50mEq/50mL
February 26, 2020
Amphastar Announces the Receipt of a MINOR CRL for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial
January 27, 2020